LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LUCD

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/21	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/12/19	22:01	PR Newswire (US)	Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/12/11	22:01	PR Newswire (US)	Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/12/07	06:10	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/12/03	22:01	PR Newswire (US)	Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/30	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/20	21:56	PR Newswire (US)	Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/19	07:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/18	22:15	PR Newswire (US)	Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/14	22:01	PR Newswire (US)	PAVmed Provides Business Update and Third Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/13	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/13	22:01	PR Newswire (US)	Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/13	06:36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/12	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/07	22:01	PR Newswire (US)	Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/11/05	22:01	PR Newswire (US)	Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/10/31	21:31	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on November 14, 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/10/30	21:31	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/10/15	20:51	PR Newswire (US)	Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA Test	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/10/09	21:01	PR Newswire (US)	Lucid Diagnostics to Participate in the 2024 Maxim Healthcare Virtual Summit	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/10/08	20:49	PR Newswire (US)	Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/10/01	21:01	PR Newswire (US)	Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/09/24	21:01	PR Newswire (US)	American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/09/17	05:30	PR Newswire (US)	PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/09/10	20:56	PR Newswire (US)	Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/09/03	20:51	PR Newswire (US)	Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/08/20	21:16	PR Newswire (US)	Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/08/13	21:16	PR Newswire (US)	The American Foregut Society Formally Requests Medical Policy Coverage of EsoGuard® to Enhance Early Detection of Esophageal Cancer	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/08/13	21:01	PR Newswire (US)	PAVmed Provides Business Update and Second Quarter 2024 Financial Results	NASDAQ:LUCD	Lucid Diagnostics Inc
2024/08/12	21:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LUCD	Lucid Diagnostics Inc